BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17034601)

  • 1. Prostate-specific antigen testing: uncovering primary care influences.
    Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
    BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J; Low M; McLeod D
    N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
    Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
    Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
    Pinnock CB; Weller DP; Marshall VR
    Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of prostate cancer screening in a UK region.
    Gavin A; McCarron P; Middleton RJ; Savage G; Catney D; O'Reilly D; Keane PF; Murray LJ
    BJU Int; 2004 Apr; 93(6):730-4. PubMed ID: 15049981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
    Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
    Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of distance learning on clinical management of LUTS in primary care: a randomised trial.
    Wolters R; Wensing M; Klomp M; Lagro-Jansen T; Weel Cv; Grol R
    Patient Educ Couns; 2005 Nov; 59(2):212-8. PubMed ID: 16257627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen testing in men older than 75 years in the United States.
    Scales CD; Curtis LH; Norris RD; Schulman KA; Albala DM; Moul JW
    J Urol; 2006 Aug; 176(2):511-4. PubMed ID: 16813879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA testing in general practice.
    Hodgson F; Obertová Z; Brown C; Lawrenson R
    J Prim Health Care; 2012 Sep; 4(3):199-204. PubMed ID: 22946067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
    Drummond FJ; Carsin AE; Sharp L; Comber H
    BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.